Surgical treatment for gastric cancer: immediate results, patterns of development of recurrences and metastases

Close metadata

Recommended articles:

Patient-centered approach to assessing tolerability of antitumor treatment for oral cavity and oropharyngeal cancer. P.A. Herzen Journal of Oncology. 2024;(2):21-26

Morphological and molecular genetic features of gastric cancer. P.A. Herzen Journal of Oncology. 2024;(3):79-84

Minimally invasive surgical treatment of extramedullary tumors at the level of craniovertebral junction: experience of the Burdenko Neurosurgical Center. Burdenko's Journal of Neurosurgery. 2024;(2):39-46

Complicated gastric cancer and modern treatment approaches. Pirogov Russian Journal of Surgery. 2024;(4):125-140

Infiltrating Endometriosis of the Distal Part of Round Uterine Ligament and It’s Association with Nuck’s Diverticulum (Literature Review and Case Report). Russian Journal of Human Reproduction. 2024;(2):112-121

Surgical technique for aspiration of soft lens nucleus with preoperative femtosecond laser-assisted fragmentation. Russian Annals of Ophthalmology. 2024;(2-2):109-115

Surgical treatment of a patient with syphilitic aortitis. Pirogov Russian Journal of Surgery. 2024;(5):123-128

Results of using endoscopic stenting of the gastric outlet and duodenum with metal self-expanding stents. Endoscopic Surgery. 2024;(3):11-20

Surgical treatment of idiopathic pulmonary artery aneurysm. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):321-328

Double-tract reconstruction after gastrectomy for gastric cancer in patients with concomitant cardiovascular diseases. Pirogov Russian Journal of Surgery. 2024;(6):58-69

The results of surgical treatment performed in the past 10 years are analyzed in 220 patients with gastric cancer. Gastrectomy with D2 lymph node dissection is now a major surgical volume for gastric cancer. This type of surgery in specialized centers is characterized by low postoperative complication and death rates. D2 lymph node dissection shows a high rate of lymphogenic metastasis, including that to the second lymph outflow collector. The adequate volume of surgical intervention into the stomach and lymph collectors results in low isolated local and regional recurrence rates. In the pattern of progressive gastric cancer, there is a preponderance of distant metastases, among which peritoneal carcinomatosis prevails. An optimal combination of adjuvant systemic (chemotherapy, targeted therapy) and local (radiotherapy) exposures is required to increase the rates of resectability and locomotor control and to prevent distant metastases.

Keywords:

gastric cancer

surgical treatment

immediate results

recurrences

metastases

Authors:

Berdov B.A.

Meditsinskiĭ radiologicheskiĭ nauchnyĭ tsentr RAMN, Obninsk

Skoropad V.Iu.

Meditsinskiĭ radiologicheskiĭ nauchnyĭ tsentr RAMN, Obninsk

Evdokimov L.V.

FGBU "Meditsinskiĭ radiologicheskiĭ nauchnyĭ tsentr" Minzdrava RF, Obninsk

List of references:

Chissov V.I., Starinskii V.V., Petrova G.V., red. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2010 godu. M.: FGU "MNIOI im. P.A. Gertsena Minzdravsotsrazvitiya Rossii"; 2011. 188s.
Chissov V.I., Davydov M.I. Onkologiya. Natsional'noe rukovodstvo. M.: GEOTAR-Media; 2008. 1072 s.
Sasako M., Sano T., Yamamoto S., Kurokawa Y. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med. 2008; 359: 453-62.
Degiuli M., Sasako M., Ponti A.; Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br. J. Surg. 2010; 97 (5): 643-9.
Yonemura Y., Wu C.C., Fukushima N., Honda I., Bandou E., Kawamura T.; East Asia Surgical Oncology Group. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology. 2006; 53 (69): 389-94.
Khvastunov R.A., Danilov S.P. Rak zheludka: standarty i individual'nye aspekty tekhniki khirurgicheskogo lecheniya. Sovremennaya onkologiya. 2007; 1: 58-66.
De Liaño Á.D., Yarnoz C., Aguilar R., Artieda C., Ortiz H. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer. 2008; 11: 96-102.
Muratore A., Zimmitti G., Lo Tesoriere R., Mellano A., Massucco P., Capussotti L. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer. Eur. J. Surg. Oncol. 2009; 35 (6): 588-92.
Portanova M., Vargas F., Lombardi E., Mena V., Carbajal R., Palacios N., Orrego J. Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer. 2007; 10: 92-7.
Lepage C., Sant M., Verdecchia A., Forman D., Esteve J., Faivre J.; and the EUROCARE working group. Operative mortality after gastric cancer resection and long-term survival differences across Europe. Br. J. Surg. 2010; 97 (2): 235-9.
Dikken J.L., van Sandick J.W., Allum W.H. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br. J. Surg. 2013; 100 (1): 83-94.
Chissov V.I., Vashakmadze L.A., Butenko A.V. Otdalennye rezul'taty lecheniya bol'nykh rakom zheludka posle vypolneniya kombinirovannykh i rasshirennykh operatsii. Rossiiskii onkologicheskii zhurnal. 2000; 1: 10-4.
Chernousov A.F., Polikarpov S.A. Limfogennoe metastazirovanie raka zheludka. Annaly khirurgii. 1997; 4: 25-31.
Jansen E.P., Boot H., van de Velde C.J., van Sandick J., Cats A., Verheij M. Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer? Recent Results Cancer Res. 2012; 196: 229-40.
Nered S.N., Klimenkov A.A. Khirurgicheskoe lechenie raka zheludka s vysokim riskom implantatsionnogo metastazirovaniya. Voprosy onkologii. 2005; 1: 75-80.
Marutsuka T., Shimada S., Shiomori K., Hayashi N., Yagi Y., Yamane T., Ogawa M. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin. Cancer Res. 2003; 9: 678-85.
Skoropad V.Yu., Berdov B.A., Loktionova O.V., Mardynskii Yu.S., Titova L.N. Sravnitel'nyi analiz otdalennykh rezul'tatov kombinirovannogo i khirurgicheskogo lecheniya perstnevidno-kletochnogo raka zheludka. Khirurgiya. 2008; 1: 13-7.
Berdov B.A., Skoropad V.Yu., Shorin M.V., Fomin S.D. Nedifferentsirovannyi rak zheludka: klinicheskie i demograficheskie osobennosti, zakonomernosti razvitiya retsidivov i metastazov, rezul'taty lecheniya. Rossiiskii onkologicheskii zhurnal. 2008; 5: 4-9.
GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration). Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010; 303 (17): 1729-37.
Kim T., Park S. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection. Int. J. Rad. Oncol. Biol. Phys. 2012; 84: e585-e592.
Skoropad V.Yu., Berdov B.A., Evdokimov L.V., Neborak Yu.T. Kombinirovannoe lechenie bol'nykh rakom zheludka (prolongirovannaya neoad''yuvantnaya khimioluchevaya terapiya + gastrektomiya D2): neposredstvennye rezul'taty 2 fazy klinicheskogo issledovaniya. Onkokhirurgiya. 2012; 3: 10-6.

Close metadata